<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16660">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01934309</url>
  </required_header>
  <id_info>
    <org_study_id>AID-OAA-TO-11-00060</org_study_id>
    <nct_id>NCT01934309</nct_id>
  </id_info>
  <brief_title>Do Clinical Decision-support Reminders for Medical Providers Improve the Do Clinical Decision-support Reminders for Medical Providers Improve the Prevalence of IPT Initiation Among HIV Positive Adults in Western Kenya?</brief_title>
  <acronym>TBTech</acronym>
  <official_title>Do Clinical Decision-support Reminders for Medical Providers Improve the Prevalence of IPT Initiation Among HIV Positive Adults in Western Kenya?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Moi University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AMPATH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regenstrief Institute, IU Center for Aging Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>InSTEDD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kijani Consulting</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <authority>Kenya: Division of Leprosy,TB and Lung Disease</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the impact of implementing a clinical decision
      support reminder system for medical providers (i.e., nurses, clinical officers, medical
      officers, consultants) to improve tuberculosis case-ﬁnding and the use of isoniazid
      preventative therapy for adults living with HIV in western Kenya.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the impact of implementing a clinical decision
      support reminder system for medical providers (i.e., nurses, clinical officers, medical
      officers, consultants) to improve tuberculosis case-ﬁnding and the use of isoniazid
      preventative therapy for adults living with HIV in western Kenya.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Prescription of Isonazid</measure>
    <time_frame>within 3 months of initial encounter</time_frame>
    <safety_issue>No</safety_issue>
    <description>Provider prescribes INH within 3 months of patient's initial encounter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to isoniazid prophylactic therapy (IPT) initiation</measure>
    <time_frame>within 3 months of initial encounter</time_frame>
    <safety_issue>No</safety_issue>
    <description>The time in weeks from a patient's initial encounter to the week the patient picks up the initial batch of INH from the pharmacy.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Initiation of isoniazid prophylactic therapy (IPT)</measure>
    <time_frame>within 3 months of initial encounter</time_frame>
    <safety_issue>No</safety_issue>
    <description>IPT will be considered &quot;initiated&quot; when a patient picks up the initial batch of the prescribed medications within 3 months of the initial encounter.</description>
  </other_outcome>
  <other_outcome>
    <measure>Isoniazid prophylactic therapy (IPT) completion</measure>
    <time_frame>9 months after treatment initiation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient completes 9-month course of IPT</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>TB reminders</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receive existing reminders plus new patient-specific reminders about TB screening, prevention, and treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No TB reminders</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Only receive existing reminders; no TB reminders</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>TB reminders</intervention_name>
    <description>The intervention to be studied involves providing clinic-based medical care providers (e.g., nurses, clinical officers, medical officers, consultants) with patient-speciﬁc clinical reminders regarding TB that are generated from a patient's electronic medical record and based on accepted clinical algorithms for TB screening and treatment.</description>
    <arm_group_label>TB reminders</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Clusters:

        Inclusion Criteria

          -  active

          -  uses HIV initial and return encounter paper forms

          -  enters data into the AMPATH medical records system (AMRS) or sends forms to central
             location for data entry

          -  prints or receives printed paper summary sheets with reminders

          -  interprets chest x-rays

          -  interprets sputum smear results

          -  prescribes IPT and dispenses INH

          -  completed an average of 10 initial adult HIV positive encounters per month in 2012

          -  HIV Care Clinic

        Exclusion Criteria -

        Patients:

        Inclusion Criteria

          -  HIV positive

          -  complete an adult initial encounter at an HIV Care Clinic during the enrollment
             period

          -  attend at least one additional appointment within 90 days after the initial encounter

        Exclusion Criteria

        - history of TB or IPT
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lameck O Diero, MBChB, MMed</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moi University College of Health Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aggrey K Keny, MBChB, MSc</last_name>
    <phone>+254-722-571562</phone>
    <email>agris57@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AMPATH</name>
      <address>
        <city>Eldoret</city>
        <country>Kenya</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adrian F Gardner, MD, MPH</last_name>
      <phone>+254-708-400176</phone>
      <email>adriangardner1@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Philip O Owiti, MBChB</last_name>
      <phone>+254-720-678625</phone>
      <email>p_owiti@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Kenya</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>September 3, 2013</lastchanged_date>
  <firstreceived_date>August 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tuberculosis</keyword>
  <keyword>isoniazid preventative therapy</keyword>
  <keyword>clinical decision support</keyword>
  <keyword>HIV</keyword>
  <keyword>Kenya</keyword>
  <keyword>eHealth</keyword>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>HIV Seropositivity</mesh_term>
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
